SCORR Marketing and the Conference Forum Collaborate on CRAACO Conference
SCORR Marketing, the full-service marketing and communications firm in the health science industry, and the Conference Forum, the presenter of strategic-level life science conferences, will collaborate on the 2020 Clinical Research as a Care Option (CRAACO) conference. The Conference Forum will include key initiatives and thought leaders from the Bridging Clinical Research & Clinical Health Care Collaborative at its CRAACO conference.
“We started the Bridging Collaborative in 2018 to bring all stakeholders together to address the gap between clinical research and health care,” said Cinda Orr, CEO at SCORR. “Moving these discussions to CRAACO means the momentum of the Bridging Collaborative will continue as we persist in exploring ways to put patients at the center of research and care.”
Although the Bridging Collaborative is changing, its key areas of focus will continue to be discussed through the CRAACO conference.
“While CRAACO approaches clinical research as a care option from a different viewpoint, we expect this collaboration will make our event stronger by bringing more voices to the conversation,” said Valerie Bowling, executive director of the Conference Forum. “This enhances our ability to facilitate meaningful discussions that ultimately benefit patients.”
CRAACO will be April 27–28, 2020, in Raleigh-Durham, NC.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
